Essais liés5clinical trials
VilleWuhanlocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT07526493

Ouvrir le site du centre

Essais cliniques associés

5
MoléculeIndication / populationPhaseNCTTitreStatut
CD19/BCMA-targeted CAR-T cells Myasthénie Phase 1 NCT07337785 CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases RECRUITING
Universal CD19 CAR-γδT Cell Injection SEP Phase 1 NCT07526493 Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases. RECRUITING
GT802 Injection SEP Phase 1 NCT07748637 A Clinical Study to Evaluate the Safety and Efficacy of GT802 Injection in the Treatment of Relapsing/Refractory Multiple Sclerosis NOT_YET_RECRUITING
Biomarkers in Autoimmune Disease of Nervous System SEP À vérifier NCT06502015 Biomarkers in Autoimmune Disease of Nervous System RECRUITING
Discussion on the Mechanism of Acupuncture on Patients with Paroxysmal Migraine Without Aura : a Randomized Controlled Clinical Trial Migraine Non applicable NCT06676670 Discussion on the Mechanism of Acupuncture on Patients with Paroxysmal Migraine Without Aura : a Randomized Controlled Clinical Trial UNKNOWN